Financials in USD. Standardized financial statements.
A compact view of how Nutra Pharma Corp. turns revenue into operating income and net income.
| Metric | FY 2025 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 | FY 2015 | FY 2014 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue? | $385,307 | $438,274 | $97,735 | $51,897 | $104,393 | $130,596 | $120,979 | $168,356 | $291,302 | $594,505 |
| Revenue Growth? | -12.1% | +348.4% | +88.3% | -50.3% | -20.1% | +7.9% | -28.1% | -42.2% | -51.0% | 0.0% |
| Cost of Revenue? | $188,679 | $189,252 | $89,268 | $36,981 | $69,678 | $116,534 | $26,903 | $223,004 | $65,805 | $114,300 |
| Gross Profit? | $196,628 | $249,022 | $8,467 | $14,916 | $34,715 | $14,062 | $94,076 | -$54,648 | $225,497 | $480,205 |
| Gross Margin? | +51.0% | +56.8% | +8.7% | +28.7% | +33.3% | +10.8% | +77.8% | -32.5% | +77.4% | +80.8% |
| Operating Expenses? | $1.66M | $2.16M | $1.93M | $1.10M | $1.20M | $1.39M | $1.48M | $1.99M | $5.99M | $2.68M |
| Operating Income? | -$1.46M | -$1.91M | -$1.92M | -$924,947 | -$1.17M | -$1.88M | -$1.38M | $2.04M | $5.77M | $2.20M |
| EBITDA? | -$1.36M | -$1.88M | -$12.54M | -$365,659 | -$6.25M | -$3.29M | -$3.66M | -$3.15M | -$4.95M | -$2.39M |
| Income Before Tax | -$2.05M | $8.18M | -$13.10M | -$769,184 | -$6.59M | -$3.88M | -$4.03M | -$3.45M | -$5.39M | -$2.53M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $313,166 | $462,111 | $128,104 |
| Net Income? | -$2.05M | $8.18M | -$13.10M | -$769,184 | -$6.59M | -$3.88M | -$4.03M | -$3.45M | -$5.39M | -$2.53M |
| EPS? | $-0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.02 | $-0.10 | $-0.08 |
| Diluted EPS? | $-0.00 | $0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.00 | $-0.02 | $-0.10 | $-0.08 |
Revenue, profitability, margins, EPS, and share-count trends over time.
Top-line demand and scale over time
Profit left after direct production costs
Core business profitability before financing and tax
Bottom-line profit after all expenses
Profit allocated to each diluted share
Share count trend that affects EPS quality
Gross, operating, and net margin quality